edilytics Profile Banner
Edilytics Profile
Edilytics

@edilytics

Followers
91
Following
13
Media
3
Statuses
252

Precision analytics for genome editing. Creators of CRISPResso2.

Joined February 2019
Don't wanna be here? Send us removal request.
@edilytics
Edilytics
4 months
Thanks for using CRISPResso!.
@ProfluentBio
Profluent
4 months
Scientific sharing fuels progress. Our friends at @Edilytics developed CRISPResso, an open-source CRISPR analysis tool built for researchers. Together with OpenCRISPR-1, the future of customizable gene editing is more accessible than ever. Check it out:
0
0
0
@edilytics
Edilytics
6 months
We are thrilled to be a part of @BioUtah!.
@BioUtah
BioUtah
6 months
🎉 Welcome, @Edilytics, to @BioUtah!. Their flagship product, CRISPResso, is the industry standard for analyzing genome editing events from NGS data, supporting diverse editing modalities with 1,650+ citations in academia & industry. 🔗 Learn more:
Tweet media one
0
0
1
@edilytics
Edilytics
11 months
We are excited to attend @CSHL's CRISPR Frontiers conference next week. Let us know if you are going and we can talk all things genome editing analysis!.
0
0
0
@edilytics
Edilytics
2 years
Congratulations to @CRISPRTX and @VertexPharma for UK approval of Casgevy to treat sickle-cell disease and β-thalassaemia. Hope to continue to see more therapies brought closer to the clinic!.
Tweet card summary image
nature.com
Nature - The landmark decision could transform the treatment of sickle-cell disease and β-thalassaemia — but the technology is expensive.
0
0
0
@edilytics
Edilytics
2 years
Excellent talk @grunewaju! #esgct . (Thanks for using CRISPResso in your slides and work)
Tweet media one
0
0
5
@edilytics
Edilytics
2 years
Happy #WorldCRISPRDay! To celebrate we would like to announce the launch of Join us in celebration by analyzing your #CRISPR experiment, happy analyzing!
0
0
1
@edilytics
Edilytics
2 years
Our team is excited to be at the @ESGCT congress next week! If you are going we would love to meet you in person, feel free to reach out so that we can connect.
0
0
0
@edilytics
Edilytics
2 years
Fascinating protocol from Changtian Pan @PCT71158462 & Yiping Qi constructing CRISPR-Combo systems for speed breeding of genome-edited plants. Thanks for using #CRISPResso in your analysis!.
Tweet card summary image
nature.com
Nature Protocols - This CRISPR-Combo system enables efficient multiplexed orthogonal genome editing and transcriptional activation in plants. Here, the use of CRISPR-Combo is demonstrated for speed...
0
0
2
@edilytics
Edilytics
2 years
Congratulations to Bestas et al. on their paper illustrating a new nuclease with lower off-targets and translocations. Thanks for using CRISPResso!
Tweet card summary image
nature.com
Nature Communications - SpCas9 unintended editing is a major concern. Here the authors report an off-target method using Duplex Sequencing with increased sensitivity for Cas9 mutation detection;...
0
0
1
@edilytics
Edilytics
2 years
Excited to be at @CSHL's #CRISPR Frontier meeting this week. If you are there too, send a DM and would love to connect!.
0
0
0
@edilytics
Edilytics
2 years
Congratulations to Alex Reed, Benjamin Cravatt, @jfernandobazan, et al. on their groundbreaking paper utilizing #CRISPR technology to show the role of TMEM164 in ferroptosis. Thanks for using #crispresso2.
Tweet card summary image
nature.com
Nature Chemical Biology - The function of a poorly characterized transmembrane protein, TMEM164, was annotated by integrated genetic dependency mapping, AlphaFold2 structural modeling and...
0
0
0
@edilytics
Edilytics
2 years
Congratulations to Mohr, Damas, Gudmand-Høyer, et al. on their groundbreaking @ACSSynBio paper utilizing #CRISPR technology for precise genetic engineering. Thank you for using #crispresso2! .
Tweet card summary image
pubs.acs.org
CRISPR-Cas12a nucleases have expanded the toolbox for targeted genome engineering in a broad range of organisms. Here, using a high-throughput engineering approach, we explored the potential of a...
0
1
2
@edilytics
Edilytics
2 years
Congrats to Kaiqin She, Yi Liu, Qinyu Zhao, et al. on their recent paper on correcting mutations and phenotypes in retinal degenerative mice using split prime editing. Thanks for using #crispresso2.
Tweet card summary image
nature.com
Signal Transduction and Targeted Therapy - Dual-AAV split prime editor corrects the mutation and phenotype in mice with inherited retinal degeneration
0
0
0
@edilytics
Edilytics
2 years
Congrats to Fuminori Tanihara, Maki Hiratat, et al. on their recent paper using electroporation and #CRISPR to cause an INS point mutation in pigs! . Thanks for using #crispresso2!.
Tweet card summary image
frontiersin.org
Just one amino acid at the carboxy-terminus of the B chain distinguishes human insulin from porcine insulin. By introducing a precise point mutation into the...
0
0
0
@edilytics
Edilytics
2 years
Congrats to @kaisa_pakari @WittbrodtLab @_ThomThum_ et al. on their recent paper on de novo PAM generation to reach initially inaccessible target sites for base editing . Thanks for using #crispresso2.
Tweet card summary image
journals.biologists.com
Summary: A combinatorial and sequential one-shot approach termed ‘inception’ is a twist on base editing that allows initially inaccessible nucleotides to be reached.
0
0
3
@edilytics
Edilytics
2 years
Congrats to Liao, Chen, Hsiao, Jiang, et al. on their recent paper using #CRISPR base editing to potentially treat inherited monogenic blood disorders!. Thanks for using #crispresso2!.
Tweet card summary image
nature.com
Nature Communications - Here, Liao and colleagues apply adenine base editor ABE8e and its PAM-less variant ABE8e-SpRY to β-thalassemia patient hematopoietic stem cells in the form of...
0
0
0
@edilytics
Edilytics
2 years
Congrats to @nicopmat #AhmedAllam et al. on their recent paper using high-throughput screen to analyze #primeediting outcomes. Thanks for using #crispresso2.
0
0
1
@edilytics
Edilytics
2 years
RT @PrimeMedicine: We're leading the next generation of gene editing and are excited to make our Twitter debut. Follow us to stay in the lo….
0
15
0